Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Feldman

Showing results (11-20 of 211) with videos related to

Pageof 22
Sort By:
The Journal of Family Practice|April 13, 2006
Hypertension: which drugs to choose for patients with cardiovascular diseaseRandy Wexler, David Feldman
Circulation|May 21, 2008
Letter by Wexler and Feldman regarding article, "Socioeconomic position, race/ethnicity, and inflammation in the multi-ethnic study of atherosclerosis"Randy Wexler, David Feldman
Primary Care|December 16, 2006
Initiation of therapy for patients with essential hypertension or comorbid conditionsRandy Wexler, David Feldman
Endocrinology and Metabolism Clinics of North America|June 1, 2010
Genetic disorders and defects in vitamin d actionPeter J Malloy, David Feldman
Annual Review of Pharmacology and Toxicology|October 13, 2010
Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin DAruna V Krishnan, David Feldman
The Journal of Steroid Biochemistry and Molecular Biology|January 25, 2005
Interaction of nuclear receptor ligands with the Vitamin D signaling pathway in prostate cancerDonna M Peehl, David Feldman
Endocrine-Related Cancer|November 21, 2009
Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatmentAruna V Krishnan, David Feldman
Rheumatic Diseases Clinics of North America|April 25, 2012
Genetic disorders and defects in vitamin D actionPeter J Malloy, David Feldman
Bonekey Reports|May 13, 2014
Mutations in the vitamin D receptor and hereditary vitamin D-resistant ricketsDavid Feldman, Peter J Malloy
Bulletin of the Hospital for Joint Disease (2013)|March 14, 2019
Varus Derotational OsteotomySurya N Mundluru, David Feldman
Pageof 22

Showing results (11-20 of 211) with videos related to

Sort By:
Pageof 22
The Journal of Family Practice|April 13, 2006
Hypertension: which drugs to choose for patients with cardiovascular diseaseRandy Wexler, David Feldman
Circulation|May 21, 2008
Letter by Wexler and Feldman regarding article, "Socioeconomic position, race/ethnicity, and inflammation in the multi-ethnic study of atherosclerosis"Randy Wexler, David Feldman
Primary Care|December 16, 2006
Initiation of therapy for patients with essential hypertension or comorbid conditionsRandy Wexler, David Feldman
Endocrinology and Metabolism Clinics of North America|June 1, 2010
Genetic disorders and defects in vitamin d actionPeter J Malloy, David Feldman
Annual Review of Pharmacology and Toxicology|October 13, 2010
Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin DAruna V Krishnan, David Feldman
The Journal of Steroid Biochemistry and Molecular Biology|January 25, 2005
Interaction of nuclear receptor ligands with the Vitamin D signaling pathway in prostate cancerDonna M Peehl, David Feldman
Endocrine-Related Cancer|November 21, 2009
Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatmentAruna V Krishnan, David Feldman
Rheumatic Diseases Clinics of North America|April 25, 2012
Genetic disorders and defects in vitamin D actionPeter J Malloy, David Feldman
Bonekey Reports|May 13, 2014
Mutations in the vitamin D receptor and hereditary vitamin D-resistant ricketsDavid Feldman, Peter J Malloy
Bulletin of the Hospital for Joint Disease (2013)|March 14, 2019
Varus Derotational OsteotomySurya N Mundluru, David Feldman
Pageof 22